← Back to front page
United States · Platforms & data · MarketBeat

CG Oncology (NASDAQ:CGON) Earns Buy Rating from Truist Financial

Published by MarketBeat · United States 26 min ago
Image from MarketBeat Media, LLC.
Image from MarketBeat Media, LLC. · MarketBeat

Detailed summary

Truist Financial restated a "buy" rating and issued a $100.00 price objective (up from $85.00) on shares of CG Oncology in a research note on Tuesday.

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading